Rana Atique Anwer, Sajid Ghafor, Huma Ahmad. Neoadjuvant Docetaxel Plus Carboplatin Versus Epirubicin Plus Cyclophosphamide Followed by Docetaxel in Triple-Negative, Early-Stage Breast Cancer. Pakistan Journal of Medical & Health Sciences 2022, 16, 356.